| # | Drug | Count |
|---|---|---|
| 0 | CANAGLIFLOZIN | 834 |
| 1 | METFORMIN | 106 |
| 2 | METFORMIN ER 500 MG | 96 |
| 3 | METFORMIN ER 750 MG | 96 |
| 4 | INSULIN GLARGINE | 88 |
| 5 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 85 |
| 6 | FUROSEMIDE | 50 |
| 7 | INSULIN LISPRO | 49 |
| 8 | ASPIRIN | 46 |
| 9 | ASPIRIN 325 MG | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 85 | 0.0468 |
| 1 | CANAGLIFLOZIN | 834 | 0.0279 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 11 | 0.0013 |
| 3 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 2 | 0.0012 |
| 4 | GLYCERIN SUPPOSITORIES | 3 | 0.0011 |
| 5 | INSULIN GLULISINE | 10 | 0.0010 |
| 6 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 30 | 0.0010 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 4 | 0.0009 |
| 8 | INSULIN GLARGINE-YFGN | 19 | 0.0008 |
| 9 | GLYCERIN SUPPOSITORY | 2 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 152 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 64 |
| 2 | Loop Diuretic [EPC] | 59 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 46 |
| 4 | Sulfonylurea [EPC] | 41 |
| 5 | Corticosteroid [EPC] | 38 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 35 |
| 7 | Proton Pump Inhibitor [EPC] | 32 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 27 |
| 9 | beta-Adrenergic Blocker [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 1 | Vitamin D2 Analog [EPC] | 9 | 0.0013 |
| 2 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 3 | Vitamin D Analog [EPC] | 10 | 0.0006 |
| 4 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 5 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 8 | Insulin [EPC] | 19 | 0.0004 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |